Iovance Biotherapeutics, Inc.
NASDAQIovance Biotherapeutics enters its June 10 earnings week carrying one of the most polarised positioning profiles in small-cap biotech: short sellers anchored at a structurally high level, yet options traders have swung to their most call-heavy stance in over a year. Short interest is the defining feature of this setup. At 26.1% of the free float, the short position has barely moved…
Snapshot as of 17 Jun 2026
Iovance Biotherapeutics enters its June 10 earnings week carrying one of the most polarised positioning profiles in small-cap biotech: short sellers anchored at a structurally high level, yet options traders have swung…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IOVA — free to start on ORTEX.
Sign up for free →Open IOVA on ORTEX